Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model

Lukasz Kuryk, Elina Haavisto, Mariangela Garofalo, Cristian Capasso, Mari Hirvinen, Sari Pesonen, Tuuli Ranki, Lotta Vassilev, Vincenzo Cerullo

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalInternational Journal of Cancer
Volume139
Issue number8
Pages (from-to)1883-1893
Number of pages11
ISSN0020-7136
DOIs
Publication statusPublished - 15 Oct 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • oncolytic adenovirus/ONCOS-102
  • immunogenic cell death
  • pemetrexed
  • cisplatin
  • carboplatin
  • mesothelioma
  • MALIGNANT PLEURAL MESOTHELIOMA
  • ONCOLYTIC ADENOVIRUS
  • CELL-DEATH
  • REPLICATING ADENOVIRUS
  • CANCER-PATIENTS
  • OVARIAN-CANCER
  • THERAPY
  • IMMUNOTHERAPY
  • COMBINATION
  • CISPLATIN
  • 317 Pharmacy

Cite this